The two vaccine companies, Pfizer and BioNTech, excluded people from their drug trials with a history of allergic reactions. Therefore, the performance of the vaccine looked safer than it will in the rollout. Past efforts to introduce RNA technology have failed, because serious autoimmune reactions occurred.
Source